Pempe, Xu Receive University Impact Awards for ResearchLiz Pempe and Weichen Xu were recognized for their outstanding research initiatives. Pempe is exploring better methods of controlling the clearance of the anticoagulant heparin from the body, while Xu is seeking a way to distinguish between slow-growing and aggressive prostate cancer.
Function of Enzyme 3-OST becomes Crystal Clear to LiuJian Liu, PhD, led a team that included PY1 Susan Woody that crystallized 3-O-sulfotransferase, an enzyme (represented by the green ribbon in the illustration) cruicial to Liu's process of creating synthetic heparin.
School to Increase Graduate Student StipendsThe stipend for all doctoral candidates in the PhD program in pharmaceutical sciences will increase by $2,500 in fall 2012 and another $2,000 in fall 2013.
UNC Research Center Receives Contract to Fight Kidney CancerWilliam Janzen of the Center for Integrative Chemical Biology and Drug Discovery and Kimryn Rathmell of the UNC School of Medicine are leading research to develop potential drug leads for treating renal cell carcinoma.
Researchers Watch as Protein Shakes off Molecular MessengersA team led by Andrew Lee, PhD, was able to observe a protein rapidly changing its shape, or conformation, causing inhibitor ligands to lose their grip.
